Ovid Therapeutics Inc. Common Stock

OVIDNASDAQ • USD
2.64 USD
↗ 0.10 (3.74%)🟢LIVE (AS OF 11:39 AM EST)
🟢Market: OPEN

Ovid Therapeutics Inc. Common Stock (OVID) trades at $2.64 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. OVID is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$2.52
High?$2.65
Low?$2.47
Prev. Close?$2.54
Volume?666.9K
Avg. Volume?2.2M
VWAP?$2.56
Rel. Volume?0.30x
Bid / Ask
Bid?$2.63 × 1.1K
Ask?$2.64 × 2.0K
Spread?$0.01
Midpoint?$2.64
Valuation & Ratios
Market Cap?479.4M
Shares Out?188.7M
Float?176.5M
Float %?90.4%
P/E Ratio?N/A
P/B Ratio?2.41
EPS?-$0.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Employees
23
Market Cap
479.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2017-05-05
Address
441 NINTH AVENUE, 14TH FLOOR
NEW YORK, NY 10001
Phone: 212-776-4381
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
54
Piotroski F-Score?0/9Weak
Altman Z-Score?9.54Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.27%High
Short Interest?18.1M
Days to Cover?8.2
Free Float176.5M
Avg Daily Volume2.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?11.97Strong
Quick Ratio?11.97Strong
Cash Ratio?1.16Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
66
2.41CHEAP▾
P/S?
Peers
100
S&P
3
330.38HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-6.8CHEAP▾
EV/Sales?
Peers
100
S&P
3
320.86HIGH▾
Returns & Efficiency
ROE?
S&P
7
-21.7%WEAK▾
ROA?
S&P
3
-19.4%WEAK▾
Cash Flow & Enterprise
FCF?$-57778000
Enterprise Value?$465.6M
Fundamentals ratios updated end of day